Drug profile · INN
buprenorphine + naloxone
SUBOXONE FILM 8/2
buprenorphine + naloxone (SUBOXONE FILM 8/2) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Pty Ltd.
TGA: approved
Patents linked 3
Pipeline programs 15
News articles 0
Drug details — buprenorphine + naloxone
- Class
- —
- Route
- —
- Patents
- 3
- Programs
- 15
- Data quality
- 0.81
Quick answer
buprenorphine + naloxone (SUBOXONE FILM 8/2) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is buprenorphine + naloxone?
buprenorphine + naloxone (SUBOXONE FILM 8/2) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Pty Ltd.
What is the brand name for buprenorphine + naloxone?
SUBOXONE FILM 8/2 is a marketed brand name for buprenorphine + naloxone. Check FDA Drugs@FDA for the current US label holder and prescribing information.